| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |